Baobab AiBIO
PrivateLast Round
Series B
Aug 10, 2023
Est. Valuation
$54M
Total Funding Raised
$17M
Company Overview
Baobab AiBIO operates in Healthcare & Life Sciences and is based in Incheon. Its latest recorded funding round was a Series A round in March 2021.
Baobab AiBIO is a biotechnology company that develops an artificial intelligence platform for drug discovery, focusing on intractable and rare diseases through quantum mechanics and cryogenic electron microscopy.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Quantum Computing, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baobab AiBIO Comparables
Compare Baobab AiBIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arontier | 85% | |
| Charm Therapeutics | 84% | |
| Gandeeva Therapeutics | 84% |
For institutional investors. Book with your work email.
Baobab AiBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 10, 2023 | ||||
| Series A | Mar 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Baobab AiBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SL Investment | Series A |
| Mirae Asset Capital | Series A |
| LSK Investment | Series A |
| Korea Development Bank | Series A |
| Samho Green Investment | Series A |
| Mirae Asset Venture Investment | Series A |
| AJU IB Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors increased 5139% MoM, from 54 to 2.8K.
- Nov 9, 2025
Monthly visitors increased 32% MoM.
For institutional investors. Book with your work email.
Baobab AiBIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Baobab AiBIO's valuation, stock price, and market status.
Is Baobab AiBIO a public or private company?
Baobab AiBIO is a private company.
What is the current stock price of Baobab AiBIO?
Baobab AiBIO is a private company, so its shares have no public market price. Caplight tracks Baobab AiBIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Baobab AiBIO worth (valuation)?
Baobab AiBIO's valuation is estimated at $54.0M based on funding round data.
Can I buy Baobab AiBIO stock?
Baobab AiBIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Baobab AiBIO's last funding round?
Baobab AiBIO's most recent funding round was Series B on August 10, 2023.
Who are the main investors in Baobab AiBIO?
Key investors in Baobab AiBIO include SL Investment, Mirae Asset Capital, LSK Investment, Korea Development Bank, Samho Green Investment.
Will Baobab AiBIO IPO soon?
No public IPO plans have been announced for Baobab AiBIO.
How can I track Baobab AiBIO secondary market activity?
Caplight tracks bids, offers, and trades in Baobab AiBIO's shares on secondary markets.